Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cryo-Cell International Inc (CCEL)
NYSE MKT:CCEL
RESEARCH TOOLSreports
Cryo-Cell International (CCEL) Stock Price & Analysis
27 Followers
CCEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.69 - $7.25
Previous Close$4.82
Volume12.19K
Average Volume (3M)13.07K
Market Cap
$39.94M
Enterprise Value$52.09M
Total Cash (Recent Filing)$1.21M
Total Debt (Recent Filing)$13.36M
Price to Earnings (P/E)16.2
Beta0.31
Next Earnings
Feb 29, 2024EPS Estimate
-$0.07Last Dividend Ex-Date
Sep 01, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding8,286,785
10 Day Avg. Volume18,863
30 Day Avg. Volume13,074
Standard Deviation0.18
R-Squared0.00791
Alpha0.00632
Financial Highlights & Ratios
Price to Book (P/B)-9.68
Price to Sales (P/S)5.08
Price to Cash Flow (P/CF)5.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.33
Enterprise Value/Gross Profit-5.92
Enterprise Value/Ebitda10.06
Forecast
1Y Price Target
$10.00Price Target Upside107.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cryo-Cell International News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CCEL FAQ
What was Cryo-Cell International Inc’s price range in the past 12 months?
Cryo-Cell International Inc lowest stock price was $2.69 and its highest was $7.25 in the past 12 months.
What is Cryo-Cell International Inc’s market cap?
Currently, no data Available
When is Cryo-Cell International Inc’s upcoming earnings report date?
Cryo-Cell International Inc’s upcoming earnings report date is Feb 29, 2024 which is in 133 days.
How were Cryo-Cell International Inc’s earnings last quarter?
Cryo-Cell International Inc released its earnings results on Oct 12, 2023. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of -$0.05 by $0.13.
Is Cryo-Cell International Inc overvalued?
According to Wall Street analysts Cryo-Cell International Inc’s price is currently Undervalued.
Does Cryo-Cell International Inc pay dividends?
Cryo-Cell International Inc pays a Notavailable dividend of $0.9 which represents an annual dividend yield of N/A. See more information on Cryo-Cell International Inc dividends here
What is Cryo-Cell International Inc’s EPS estimate?
Cryo-Cell International Inc’s EPS estimate is -$0.07.
How many shares outstanding does Cryo-Cell International Inc have?
Cryo-Cell International Inc has 8,286,785 shares outstanding.
What happened to Cryo-Cell International Inc’s price movement after its last earnings report?
Cryo-Cell International Inc reported an EPS of $0.08 in its last earnings report, beating expectations of -$0.05. Following the earnings report the stock price went down -2.381%.
Which hedge fund is a major shareholder of Cryo-Cell International Inc?
Currently, no hedge funds are holding shares in CCEL
---
Cryo-Cell International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (107.47% Upside)
$10.00 (107.47% Upside)
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.60%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
4.54%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cryo-Cell International Inc
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage; and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded on September 11, 1989 and is headquartered in Oldsmar, FL.
---
Top 5 ETFs holding CCEL
Vanguard Total Stock Market ETF
$379.96K
Up to five ETFs with an Outperform Smart Score that hold CCEL. The ETFs are listed according to market value of CCEL within the ETF
Cogent Biosciences
―
American CryoStem
―
Brainstorm Cell Therapeutics
―
Cytosorbents
―
---